{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:31Z","timestamp":1782602551768,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.gastro.2016.03.036","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T21:26:39Z","timestamp":1459632399000},"page":"130-139.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension"],"prefix":"10.1053","volume":"151","author":[{"given":"Vito","family":"Di Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Calvaruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Bavetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cabibbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Camm\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Grimaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria Maria","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2016.03.036_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A\u00a0morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"D'Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.03.036_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hep.21492","article-title":"Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study","volume":"45","author":"Bruno","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2016.03.036_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2016.03.036_bib7","article-title":"Effects of sustained virological response (SVR) on the risk of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 23,309 patients with Hepatitis C infection","author":"Hill","year":"2014","journal-title":"AASLD"},{"key":"10.1053\/j.gastro.2016.03.036_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multi-state models and\u00a0competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2016.03.036_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2012.10.023","article-title":"The natural history of compensated HCV-related cirrhosis: a prospective long-term study","volume":"58","author":"Gomez","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2014.03.051","article-title":"Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis","volume":"147","author":"H\u00e9zode","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.03.036_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(14)61225-3","article-title":"Hepatitis C beware\u2212the end is nigh","volume":"384","author":"Gane","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2016.03.036_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2007.04.020","article-title":"Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial","volume":"47","author":"Di Marco","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2893.2012.01637.x","article-title":"Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of peg-interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices","volume":"20","author":"Di Marco","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2016.03.036_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension","volume":"33","author":"de Franchis","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"319","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.03.036_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in\u00a0portal hypertension: report of the Baveno V consensus\u00a0workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib25","first-page":"11430","article-title":"HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?","volume":"6","author":"Asselah","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/gutjnl-2014-308166","article-title":"Strategies for the treatment of hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?","volume":"64","author":"Innes","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.03.036_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib28","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers\u00a0to prevent gastroesophageal varices in\u00a0patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.03.036_bib29","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1053\/j.gastro.2010.02.058","article-title":"Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C","volume":"138","author":"Fontana","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.03.036_bib30","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hep.23528","article-title":"Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study","volume":"51","author":"Bruno","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1572-0241.2000.01775.x","article-title":"Natural history of\u00a0cirrhotic patients with small esophageal varices: a\u00a0prospective study","volume":"95","author":"Zoli","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2016.03.036_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A\u00a0placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis","volume":"127","author":"Merkel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.03.036_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.03.036_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/jvh.12114","article-title":"Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis","volume":"20","author":"Calvaruso","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2016.03.036_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2014.02.024","article-title":"Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study","volume":"60","author":"Colecchia","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2014.02.022","article-title":"Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication","volume":"61","author":"Huang","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.03.036_bib38","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","article-title":"Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus","volume":"47","author":"Veldt","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.26087","article-title":"Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C","volume":"57","author":"Arase","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.03.036_bib40","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir\u00a0and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2016.03.036_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/M14-0741","article-title":"Treatment of hepatitis C virus infection: is it time for the internist to take the reins?","volume":"161","author":"Kottilil","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2016.03.036_bib42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1053\/j.gastro.2012.05.054","article-title":"Predicted effects of treatment for HCV infection vary among European countries","volume":"143","author":"Deuffic-Burban","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650851630049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650851630049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T19:30:43Z","timestamp":1536867043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650851630049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S001650851630049X"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2016.03.036","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2016.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the AGA Institute","name":"copyright","label":"Copyright"}]}}